However, whether Erk1/2 acts as the initiator of oxidative stress in HCC pathogenesis, and whether its activation exerts pro‐ferroptotic or anti‐ferroptotic effects in HCC remain unclear. Here, MAPK3 is linked to hepatocellular carcinoma.